Why is my dehydroepiandrosterone sulfate (DHEA‑S) level elevated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Elevated DHEA-S: Diagnostic Approach

An elevated DHEA-S level requires immediate evaluation to exclude adrenal tumors when levels exceed 600 µg/dL (16,000 nmol/L), followed by systematic assessment for PCOS, non-classic congenital adrenal hyperplasia, and Cushing's disease based on the degree of elevation and clinical context. 1

Critical Threshold for Urgent Evaluation

DHEA-S >600 µg/dL (16,000 nmol/L) indicates possible androgen-secreting adrenal cortical adenoma and requires urgent abdominal imaging (CT or MRI). 1 This threshold represents a medical emergency as these tumors are often associated with hypercorticism and require rapid surgical intervention.

Most Common Causes by Clinical Context

In Women of Reproductive Age (20-29 years)

The most frequent cause is polycystic ovary syndrome (PCOS), particularly non-classic phenotypes (B and C). Elevated DHEA-S occurs in approximately 33% of young PCOS patients and is associated with:

  • Higher testosterone and androstenedione levels 2
  • Increased prevalence in non-classic PCOS phenotypes (B or C) compared to classic phenotype A 2
  • Presence of acne (independent of testosterone levels) 3
  • Paradoxically reduced risk of abdominal obesity 3

Important caveat: DHEA-S levels decline by 40% from the twenties to thirties, so age-appropriate reference ranges are critical 2. A "high" DHEA-S in a 40-year-old may be normal for a 25-year-old.

In Anovulatory Women

50% of euprolactinemic anovulatory women have elevated DHEA-S, and notably, 77% of these women are non-hirsute 4. This challenges the assumption that elevated adrenal androgens always present with obvious clinical hyperandrogenism.

Systematic Diagnostic Algorithm

Step 1: Confirm Elevation and Assess Severity

  • Repeat DHEA-S measurement to confirm
  • Check testosterone and androstenedione levels (typically elevated together) 2
  • If DHEA-S >600 µg/dL → proceed immediately to imaging 1

Step 2: Rule Out Adrenal Pathology

For moderately elevated DHEA-S (<600 µg/dL):

  • Perform 1-mg overnight dexamethasone suppression test to evaluate for Cushing's disease 5
  • Cushing's disease with macronodular adrenal hyperplasia can present with markedly elevated DHEA-S (>10,000 ng/mL) 6
  • Check morning cortisol and ACTH levels

Step 3: Evaluate for PCOS

Look for:

  • Irregular menstrual cycles
  • Clinical hyperandrogenism (hirsutism, acne, androgenic alopecia)
  • Measure 17-hydroxyprogesterone (17-OHP) to screen for non-classic 21-hydroxylase deficiency 1
  • Consider ACTH stimulation test if 17-OHP is borderline elevated

Key finding: In PCOS patients with elevated DHEA-S, approximately 34% show exaggerated DHEA-S response to ACTH stimulation, suggesting mild 3β-hydroxysteroid dehydrogenase deficiency 4

Step 4: Assess Metabolic Context

  • Measure SHBG (typically reduced in metabolic syndrome, obesity, insulin resistance) 1
  • Calculate free testosterone using total testosterone and SHBG
  • Evaluate for insulin resistance with fasting glucose and insulin
  • Check lipid profile

Clinical pearl: Unlike testosterone, elevated DHEA-S in PCOS is inversely correlated with waist circumference, BMI, insulin resistance, and triglycerides 3. This suggests DHEA-S elevation may represent a distinct metabolic subtype.

Rare but Important Causes

Medication and Systemic Conditions

  • Thyroid hormone therapy or analogues can alter SHBG and androgen interpretation 1
  • Antiepileptic drugs (e.g., valproate) increase SHBG 1
  • Hyperthyroidism or liver disease (particularly cirrhosis) can elevate SHBG and affect total testosterone interpretation 1

Genetic Enzyme/Transporter Defects

Very rare cases involve:

  • Steroid sulfatase (STS) mutations 7
  • Breast cancer resistance protein (BCRP) variants affecting DHEA-S efflux 7
  • These should only be considered after excluding all common causes

Common Pitfalls to Avoid

  1. Ignoring age-specific reference ranges: DHEA-S declines dramatically with age; use age-matched controls 2

  2. Assuming normal testosterone excludes hyperandrogenism: Isolated DHEA-S elevation occurs, particularly with reduced SHBG 1

  3. Missing non-hirsute hyperandrogenism: 77% of anovulatory women with elevated DHEA-S lack hirsutism 4

  4. Failing to check timing in menstruating women: Verify cycle phase and avoid assaying during thyroid hormone or estrogenic medication use 1

  5. Not pursuing imaging for very high levels: Any DHEA-S >600 µg/dL requires imaging regardless of other findings 1

Clinical Significance Beyond Diagnosis

Elevated DHEA-S in PCOS predicts:

  • Higher overall androgen production 2
  • Increased acne risk (OR 2.15 for DHEA-S >6.68 µmol/L) 3
  • Lower risk of abdominal obesity and metabolic complications 3

This suggests DHEA-S elevation may identify a PCOS subtype with different metabolic trajectory despite higher androgen burden.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.